Organoids Industry Research Report 2023
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
Highlights
The global Organoids market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.
North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.
Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Organoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids.
The Organoids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organoids market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Organoids type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Organoids are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Organoids segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Organoids market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Organoids market.
Organoids Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Organoids market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Organoids industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Organoids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
Highlights
The global Organoids market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.
North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.
Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Organoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids.
The Organoids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organoids market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Thermo Fisher Scientific
- Merck
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- amsbio
- Cellesce
- DefiniGEN
- OcellO B.V.
- HUB Oranoid Technology
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
Global markets are presented by Organoids type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Organoids are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Organoids segment by Type
- 3D Organoid Culture
- Biochemical Cues
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Organoids market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Organoids market.
Organoids Segment by Application
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Organoids market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Organoids industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Organoids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Organoids Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Organoids Revenue Market Share by Type (2018-2023)
Table 7. Global Organoids Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Organoids Revenue Market Share by Type (2024-2029)
Table 9. Global Organoids Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Organoids Revenue Market Share by Application (2018-2023)
Table 11. Global Organoids Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Organoids Revenue Market Share by Application (2024-2029)
Table 13. Global Organoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Organoids Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Organoids Market Share by Region (2018-2023)
Table 16. Global Organoids Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Organoids Market Share by Region (2024-2029)
Table 18. Organoids Market Trends
Table 19. Organoids Market Drivers
Table 20. Organoids Market Challenges
Table 21. Organoids Market Restraints
Table 22. Global Top Organoids Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Organoids Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Organoids Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Organoids, Headquarters and Area Served
Table 26. Global Organoids Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Organoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 45. Thermo Fisher Scientific Company Detail
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Organoids Product
Table 48. Thermo Fisher Scientific Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 49. Thermo Fisher Scientific Recent Development
Table 50. Merck Company Detail
Table 51. Merck Business Overview
Table 52. Merck Organoids Product
Table 53. Merck Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 54. Merck Recent Development
Table 55. Corning Company Detail
Table 56. Corning Business Overview
Table 57. Corning Organoids Product
Table 58. Corning Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 59. Corning Recent Development
Table 60. STEMCELL Technologies Company Detail
Table 61. STEMCELL Technologies Business Overview
Table 62. STEMCELL Technologies Organoids Product
Table 63. STEMCELL Technologies Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 64. STEMCELL Technologies Recent Development
Table 65. Lonza Company Detail
Table 66. Lonza Business Overview
Table 67. Lonza Organoids Product
Table 68. Lonza Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 69. Lonza Recent Development
Table 70. Prellis Biologics Company Detail
Table 71. Prellis Biologics Business Overview
Table 72. Prellis Biologics Organoids Product
Table 73. Prellis Biologics Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 74. Prellis Biologics Recent Development
Table 75. amsbio Company Detail
Table 76. amsbio Business Overview
Table 77. amsbio Organoids Product
Table 78. amsbio Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 79. amsbio Recent Development
Table 80. Cellesce Company Detail
Table 81. Cellesce Business Overview
Table 82. Cellesce Organoids Product
Table 83. Cellesce Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 84. Cellesce Recent Development
Table 85. DefiniGEN Company Detail
Table 86. DefiniGEN Business Overview
Table 87. DefiniGEN Organoids Product
Table 88. DefiniGEN Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 89. DefiniGEN Recent Development
Table 90. OcellO B.V. Company Detail
Table 91. OcellO B.V. Business Overview
Table 92. OcellO B.V. Organoids Product
Table 93. OcellO B.V. Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 94. OcellO B.V. Recent Development
Table 95. HUB Oranoid Technology Company Detail
Table 96. HUB Oranoid Technology Business Overview
Table 97. HUB Oranoid Technology OrganoidsProduct
Table 98. HUB Oranoid Technology Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 99. HUB Oranoid Technology Recent Development
Table 100. 3Dnamics Inc. Company Detail
Table 101. 3Dnamics Inc. Business Overview
Table 102. 3Dnamics Inc. OrganoidsProduct
Table 103. 3Dnamics Inc. Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 104. 3Dnamics Inc. Recent Development
Table 105. Organoid Therapeutics Company Detail
Table 106. Organoid Therapeutics Business Overview
Table 107. Organoid Therapeutics OrganoidsProduct
Table 108. Organoid Therapeutics Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 109. Organoid Therapeutics Recent Development
Table 110. InSphero Company Detail
Table 111. InSphero Business Overview
Table 112. InSphero OrganoidsProduct
Table 113. InSphero Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 114. InSphero Recent Development
Table 115. Thermo Fisher Scientific Company Information
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 118. Thermo Fisher Scientific Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 119. Thermo Fisher Scientific Recent Development
Table 120. Merck Company Information
Table 121. Merck Business Overview
Table 122. Merck Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 123. Merck Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 124. Merck Recent Development
Table 125. Corning Company Information
Table 126. Corning Business Overview
Table 127. Corning Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 128. Corning Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 129. Corning Recent Development
Table 130. STEMCELL Technologies Company Information
Table 131. STEMCELL Technologies Business Overview
Table 132. STEMCELL Technologies Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 133. STEMCELL Technologies Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 134. STEMCELL Technologies Recent Development
Table 135. Lonza Company Information
Table 136. Lonza Business Overview
Table 137. Lonza Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 138. Lonza Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 139. Lonza Recent Development
Table 140. Prellis Biologics Company Information
Table 141. Prellis Biologics Business Overview
Table 142. Prellis Biologics Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 143. Prellis Biologics Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 144. Prellis Biologics Recent Development
Table 145. amsbio Company Information
Table 146. amsbio Business Overview
Table 147. amsbio Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 148. amsbio Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 149. amsbio Recent Development
Table 150. Cellesce Company Information
Table 151. Cellesce Business Overview
Table 152. Cellesce Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 153. Cellesce Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 154. Cellesce Recent Development
Table 155. DefiniGEN Company Information
Table 156. DefiniGEN Business Overview
Table 157. DefiniGEN Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 158. DefiniGEN Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 159. DefiniGEN Recent Development
Table 160. OcellO B.V. Company Information
Table 161. OcellO B.V. Business Overview
Table 162. OcellO B.V. Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 163. OcellO B.V. Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 164. OcellO B.V. Recent Development
Table 165. HUB Oranoid Technology Company Information
Table 166. HUB Oranoid Technology Business Overview
Table 167. HUB Oranoid Technology OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 168. HUB Oranoid Technology Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 169. HUB Oranoid Technology Recent Development
Table 170. 3Dnamics Inc. Company Information
Table 171. 3Dnamics Inc. Business Overview
Table 172. 3Dnamics Inc. OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 173. 3Dnamics Inc. Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 174. 3Dnamics Inc. Recent Development
Table 175. Organoid Therapeutics Company Information
Table 176. Organoid Therapeutics Business Overview
Table 177. Organoid Therapeutics OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 178. Organoid Therapeutics Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 179. Organoid Therapeutics Recent Development
Table 180. InSphero Company Information
Table 181. InSphero Business Overview
Table 182. InSphero OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 183. InSphero Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 184. InSphero Recent Development
Table 185. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Organoids Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Organoids Revenue Market Share by Type (2018-2023)
Table 7. Global Organoids Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Organoids Revenue Market Share by Type (2024-2029)
Table 9. Global Organoids Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Organoids Revenue Market Share by Application (2018-2023)
Table 11. Global Organoids Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Organoids Revenue Market Share by Application (2024-2029)
Table 13. Global Organoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Organoids Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Organoids Market Share by Region (2018-2023)
Table 16. Global Organoids Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Organoids Market Share by Region (2024-2029)
Table 18. Organoids Market Trends
Table 19. Organoids Market Drivers
Table 20. Organoids Market Challenges
Table 21. Organoids Market Restraints
Table 22. Global Top Organoids Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Organoids Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Organoids Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Organoids, Headquarters and Area Served
Table 26. Global Organoids Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Organoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Organoids Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Organoids Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Organoids Market Size by Country (2024-2029) & (US$ Million)
Table 45. Thermo Fisher Scientific Company Detail
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Organoids Product
Table 48. Thermo Fisher Scientific Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 49. Thermo Fisher Scientific Recent Development
Table 50. Merck Company Detail
Table 51. Merck Business Overview
Table 52. Merck Organoids Product
Table 53. Merck Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 54. Merck Recent Development
Table 55. Corning Company Detail
Table 56. Corning Business Overview
Table 57. Corning Organoids Product
Table 58. Corning Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 59. Corning Recent Development
Table 60. STEMCELL Technologies Company Detail
Table 61. STEMCELL Technologies Business Overview
Table 62. STEMCELL Technologies Organoids Product
Table 63. STEMCELL Technologies Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 64. STEMCELL Technologies Recent Development
Table 65. Lonza Company Detail
Table 66. Lonza Business Overview
Table 67. Lonza Organoids Product
Table 68. Lonza Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 69. Lonza Recent Development
Table 70. Prellis Biologics Company Detail
Table 71. Prellis Biologics Business Overview
Table 72. Prellis Biologics Organoids Product
Table 73. Prellis Biologics Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 74. Prellis Biologics Recent Development
Table 75. amsbio Company Detail
Table 76. amsbio Business Overview
Table 77. amsbio Organoids Product
Table 78. amsbio Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 79. amsbio Recent Development
Table 80. Cellesce Company Detail
Table 81. Cellesce Business Overview
Table 82. Cellesce Organoids Product
Table 83. Cellesce Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 84. Cellesce Recent Development
Table 85. DefiniGEN Company Detail
Table 86. DefiniGEN Business Overview
Table 87. DefiniGEN Organoids Product
Table 88. DefiniGEN Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 89. DefiniGEN Recent Development
Table 90. OcellO B.V. Company Detail
Table 91. OcellO B.V. Business Overview
Table 92. OcellO B.V. Organoids Product
Table 93. OcellO B.V. Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 94. OcellO B.V. Recent Development
Table 95. HUB Oranoid Technology Company Detail
Table 96. HUB Oranoid Technology Business Overview
Table 97. HUB Oranoid Technology OrganoidsProduct
Table 98. HUB Oranoid Technology Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 99. HUB Oranoid Technology Recent Development
Table 100. 3Dnamics Inc. Company Detail
Table 101. 3Dnamics Inc. Business Overview
Table 102. 3Dnamics Inc. OrganoidsProduct
Table 103. 3Dnamics Inc. Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 104. 3Dnamics Inc. Recent Development
Table 105. Organoid Therapeutics Company Detail
Table 106. Organoid Therapeutics Business Overview
Table 107. Organoid Therapeutics OrganoidsProduct
Table 108. Organoid Therapeutics Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 109. Organoid Therapeutics Recent Development
Table 110. InSphero Company Detail
Table 111. InSphero Business Overview
Table 112. InSphero OrganoidsProduct
Table 113. InSphero Revenue in Organoids Business (2017-2022) & (US$ Million)
Table 114. InSphero Recent Development
Table 115. Thermo Fisher Scientific Company Information
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 118. Thermo Fisher Scientific Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 119. Thermo Fisher Scientific Recent Development
Table 120. Merck Company Information
Table 121. Merck Business Overview
Table 122. Merck Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 123. Merck Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 124. Merck Recent Development
Table 125. Corning Company Information
Table 126. Corning Business Overview
Table 127. Corning Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 128. Corning Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 129. Corning Recent Development
Table 130. STEMCELL Technologies Company Information
Table 131. STEMCELL Technologies Business Overview
Table 132. STEMCELL Technologies Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 133. STEMCELL Technologies Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 134. STEMCELL Technologies Recent Development
Table 135. Lonza Company Information
Table 136. Lonza Business Overview
Table 137. Lonza Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 138. Lonza Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 139. Lonza Recent Development
Table 140. Prellis Biologics Company Information
Table 141. Prellis Biologics Business Overview
Table 142. Prellis Biologics Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 143. Prellis Biologics Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 144. Prellis Biologics Recent Development
Table 145. amsbio Company Information
Table 146. amsbio Business Overview
Table 147. amsbio Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 148. amsbio Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 149. amsbio Recent Development
Table 150. Cellesce Company Information
Table 151. Cellesce Business Overview
Table 152. Cellesce Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 153. Cellesce Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 154. Cellesce Recent Development
Table 155. DefiniGEN Company Information
Table 156. DefiniGEN Business Overview
Table 157. DefiniGEN Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 158. DefiniGEN Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 159. DefiniGEN Recent Development
Table 160. OcellO B.V. Company Information
Table 161. OcellO B.V. Business Overview
Table 162. OcellO B.V. Organoids Revenue in Organoids Business (2018-2023) & (US$ Million)
Table 163. OcellO B.V. Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 164. OcellO B.V. Recent Development
Table 165. HUB Oranoid Technology Company Information
Table 166. HUB Oranoid Technology Business Overview
Table 167. HUB Oranoid Technology OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 168. HUB Oranoid Technology Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 169. HUB Oranoid Technology Recent Development
Table 170. 3Dnamics Inc. Company Information
Table 171. 3Dnamics Inc. Business Overview
Table 172. 3Dnamics Inc. OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 173. 3Dnamics Inc. Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 174. 3Dnamics Inc. Recent Development
Table 175. Organoid Therapeutics Company Information
Table 176. Organoid Therapeutics Business Overview
Table 177. Organoid Therapeutics OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 178. Organoid Therapeutics Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 179. Organoid Therapeutics Recent Development
Table 180. InSphero Company Information
Table 181. InSphero Business Overview
Table 182. InSphero OrganoidsRevenue in Organoids Business (2018-2023) & (US$ Million)
Table 183. InSphero Revenue in Organoids Business (2018-2023) & (US$ Million) Portfolio
Table 184. InSphero Recent Development
Table 185. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Organoids Product Picture
Figure 5. Global Organoids Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Organoids Market Share by Type: 2022 VS 2029
Figure 7. 3D Organoid Culture Product Picture
Figure 8. Biochemical Cues Product Picture
Figure 9. Global Organoids Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Organoids Market Share by Application: 2022 VS 2029
Figure 11. Biopharmaceutical Companies Product Picture
Figure 12. Contract Research Organizations Product Picture
Figure 13. Academics and Research Institutes Product Picture
Figure 14. Global Organoids Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Organoids Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Organoids Market Share by Region: 2022 VS 2029
Figure 17. Global Organoids Market Share by Players in 2022
Figure 18. Global Organoids Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Organoids Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Organoids Market Share by Country (2018-2029)
Figure 23. United States Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Organoids Market Share by Country (2018-2029)
Figure 27. Germany Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Organoids Market Share by Country (2018-2029)
Figure 35. China Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Organoids Market Share by Country (2018-2029)
Figure 43. Mexico Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Organoids Market Share by Country (2018-2029)
Figure 47. Turkey Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Organoids Business (2018-2023)
Figure 52. Corning Revenue Growth Rate in Organoids Business (2018-2023)
Figure 53. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2018-2023)
Figure 54. Lonza Revenue Growth Rate in Organoids Business (2018-2023)
Figure 55. Prellis Biologics Revenue Growth Rate in Organoids Business (2018-2023)
Figure 56. amsbio Revenue Growth Rate in Organoids Business (2018-2023)
Figure 57. Cellesce Revenue Growth Rate in Organoids Business (2018-2023)
Figure 58. DefiniGEN Revenue Growth Rate in Organoids Business (2018-2023)
Figure 59. OcellO B.V. Revenue Growth Rate in Organoids Business (2018-2023)
Figure 60. HUB Oranoid Technology Revenue Growth Rate in Organoids Business (2018-2023)
Figure 61. 3Dnamics Inc. Revenue Growth Rate in Organoids Business (2018-2023)
Figure 62. Organoid Therapeutics Revenue Growth Rate in Organoids Business (2018-2023)
Figure 63. InSphero Revenue Growth Rate in Organoids Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Organoids Product Picture
Figure 5. Global Organoids Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Organoids Market Share by Type: 2022 VS 2029
Figure 7. 3D Organoid Culture Product Picture
Figure 8. Biochemical Cues Product Picture
Figure 9. Global Organoids Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Organoids Market Share by Application: 2022 VS 2029
Figure 11. Biopharmaceutical Companies Product Picture
Figure 12. Contract Research Organizations Product Picture
Figure 13. Academics and Research Institutes Product Picture
Figure 14. Global Organoids Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Organoids Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Organoids Market Share by Region: 2022 VS 2029
Figure 17. Global Organoids Market Share by Players in 2022
Figure 18. Global Organoids Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Organoids Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Organoids Market Share by Country (2018-2029)
Figure 23. United States Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Organoids Market Share by Country (2018-2029)
Figure 27. Germany Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Organoids Market Share by Country (2018-2029)
Figure 35. China Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Organoids Market Share by Country (2018-2029)
Figure 43. Mexico Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Organoids Market Share by Country (2018-2029)
Figure 47. Turkey Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Organoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Organoids Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Organoids Business (2018-2023)
Figure 52. Corning Revenue Growth Rate in Organoids Business (2018-2023)
Figure 53. STEMCELL Technologies Revenue Growth Rate in Organoids Business (2018-2023)
Figure 54. Lonza Revenue Growth Rate in Organoids Business (2018-2023)
Figure 55. Prellis Biologics Revenue Growth Rate in Organoids Business (2018-2023)
Figure 56. amsbio Revenue Growth Rate in Organoids Business (2018-2023)
Figure 57. Cellesce Revenue Growth Rate in Organoids Business (2018-2023)
Figure 58. DefiniGEN Revenue Growth Rate in Organoids Business (2018-2023)
Figure 59. OcellO B.V. Revenue Growth Rate in Organoids Business (2018-2023)
Figure 60. HUB Oranoid Technology Revenue Growth Rate in Organoids Business (2018-2023)
Figure 61. 3Dnamics Inc. Revenue Growth Rate in Organoids Business (2018-2023)
Figure 62. Organoid Therapeutics Revenue Growth Rate in Organoids Business (2018-2023)
Figure 63. InSphero Revenue Growth Rate in Organoids Business (2018-2023)
